Company / SG&A per Share
Inmune Bio, Inc. SG&A per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.43
FY2025
5-year range
$0.43 / $0.54
FY2021-FY2025
Trend
-20.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 7 years, ranging from $0.07 in FY2018 to $0.56 in FY2020.
Based on SEC 10-K filings.
0.43 in FY2025 with a 5-year CAGR of -5.3%.
Improved from $0.52 to $0.43 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -4.8%
- 5-Year CAGR
- -5.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share decreased 20.6% year-over-year.
- Peak sg&a per share was recorded in FY2020.
- Lowest sg&a per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 49.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.43 | -20.6% |
| FY2024 | $0.54 | +3.9% |
| FY2023 | $0.52 | +4.7% |
| FY2022 | $0.49 | +5.1% |
| FY2021 | $0.47 | -16.1% |
| FY2020 | $0.56 | +750.9% |
| FY2018 | $0.07 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026